Qifeng Yang

19.6k citations
348 papers · 13.0k · 4 hit papers · h-index 56

Impact in

    • Cancer-related molecular mechanisms research
    • MicroRNA in disease regulation
    • Breast Cancer Treatment Studies
  • Oncology top 0.5%
    • Cancer Cells and Metastasis

Papers in

    • Circular RNAs in diseases 34
    • RNA modifications and cancer 26
    • Cancer-related molecular mechanisms research 40
    • Breast Cancer Treatment Studies 37
    • MicroRNA in disease regulation 32

Qifeng Yang

336 papers receiving 12.8k citations

Qifeng Yang's Hit Papers

Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets 2019 · 665 citations
6650+6+13Years since publication250500750

Peers

Qifeng Yang
Comparison fields: 5 of 169
  • Cancer Research 4.7k
  • Oncology 3.4k
  • Pathology and Forensic Medicine 1.7k
  • Molecular Biology 6.3k
  • Immunology 872
Replace Melinda E. Sanders with:
Melinda E. Sanders United States
Jun Yokota Japan
Brian D. Lehmann United States
Øystein Fluge Norway
Thomas J. Giordano United States
Tatsuhiro Shibata Japan
Filip Jankú United States
Bryan T. Hennessy Ireland
Pierfrancesco Tassone Italy
Russell R. Broaddus United States
Qifeng Yang relative to Melinda E. Sanders United States Melinda E. Sanders's profile →
Citations per field
00.5×1.5×1.8×
Melinda E. Sanders · 1×
Citations per year

Countries citing papers authored by Qifeng Yang

Since Specialization
Citations

This map shows the geographic impact of Qifeng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qifeng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qifeng Yang more than expected).

Fields of papers citing papers by Qifeng Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qifeng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qifeng Yang. The network helps show where Qifeng Yang may publish in the future.

Co-authors

The 25 scholars most cited alongside Qifeng Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Qifeng Yang Line = papers co-authored together Qifeng Yang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 348 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Locoregional Relapse and Distant Metastasis in Conservatively Managed Triple Negative Early-Stage Breast Cancer
Hit paper breakdown →
2006880
2
Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets
Hit paper breakdown →
2019665
3
VCAM-1 Promotes Osteolytic Expansion of Indolent Bone Micrometastasis of Breast Cancer by Engaging α4β1-Positive Osteoclast Progenitors
Hit paper breakdown →
2011403
4
circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer
Hit paper breakdown →
2019344
5 2009343
6 2017240
7 2018239
8 2012225
9 2011209
10 2021183
11 2018154
12 2018147
13 2011145
14 2022139
15 2021138
16 2013131
17 2014129
18 2017126
19 2010117
20 2019114

About Qifeng Yang

Qifeng Yang is a scholar working on Molecular Biology, Cancer Research, Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 348 papers that have together received 13.0k indexed citations. Recurring topics across this work include Cancer Mechanisms and Therapy (41 papers), Cancer-related molecular mechanisms research (40 papers), Breast Cancer Treatment Studies (37 papers), Circular RNAs in diseases (34 papers), MicroRNA in disease regulation (32 papers), RNA modifications and cancer (26 papers), Cancer-related Molecular Pathways (24 papers) and Peptidase Inhibition and Analysis (21 papers). The work is most often cited by research in Cancer Research (4.7k citations), Oncology (3.4k citations), Pathology and Forensic Medicine (1.7k citations), Molecular Biology (6.3k citations) and Immunology (872 citations). Qifeng Yang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Bruce G. Haffty, Ning Zhang, Hanwen Zhang, Yiran Liang, Xiaojin Song, Meena S. Moran, Yaming Li, Bing Chen, Xiaolong Wang and Xiaoyan Li. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, PLoS ONE, Cell Death and Disease, International Journal of Oncology and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact